Effects of Red Ginseng on Liver Function

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-01

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Korea Red Ginseng (KRG) has effect on liver function

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

NCT02331589

Fatigue

COMPLETED PHASE4

The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation

NCT00730951

Hypertension

COMPLETED PHASE2

Safety for 24 Weeks Intake of Korean Red Ginseng in Adults

NCT02428998

Healthy Diabetes Hypertension +1 more

COMPLETED NA

Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension

NCT02211352

Hypertension

COMPLETED PHASE2

Stress Relief Effect of Korean Red Ginseng

NCT01542905

Stress Relief

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Korea Red Ginseng (KRG) has been known as a natural product with anti-inflammatory effect in liver disease. Gut microbiota plays an important roles in the pathophysiology of nonalcoholic statohepatitis (NASH). We evaluated the effect of KRG on the pathophysiology of NASH

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ginseng trial

compare experimental group to controlled group

Group Type EXPERIMENTAL

Red ginseng

Intervention Type DIETARY_SUPPLEMENT

Red ginseng tablet 120g

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Red ginseng

Red ginseng tablet 120g

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Red ginseng tablet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* AST or ALT level \> 50 IU/L

Exclusion Criteria

* Viral hepatitis
* Alcoholic hepatitis
* Autoimmune hepatitis
* Pancreatitis
* Hemochromatosis
* Wilson's disease
* Drug induced liver injury
* Cancer

Minimum Eligible Age

37 Years

Maximum Eligible Age

63 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No